FIORENZATO, ELEONORA
 Distribuzione geografica
Continente #
NA - Nord America 4.105
AS - Asia 2.798
EU - Europa 2.058
AF - Africa 416
SA - Sud America 410
Continente sconosciuto - Info sul continente non disponibili 121
OC - Oceania 36
Totale 9.944
Nazione #
US - Stati Uniti d'America 3.779
IT - Italia 1.136
SG - Singapore 816
CN - Cina 457
VN - Vietnam 441
HK - Hong Kong 391
BR - Brasile 222
BD - Bangladesh 105
CA - Canada 102
NL - Olanda 94
DE - Germania 93
FR - Francia 89
IN - India 80
SE - Svezia 69
FI - Finlandia 61
GB - Regno Unito 60
PL - Polonia 54
RU - Federazione Russa 45
IQ - Iraq 37
CO - Colombia 36
JP - Giappone 35
CH - Svizzera 34
PH - Filippine 34
MX - Messico 31
AR - Argentina 30
SA - Arabia Saudita 29
ID - Indonesia 28
ZA - Sudafrica 28
ES - Italia 26
PK - Pakistan 24
TR - Turchia 24
UA - Ucraina 24
CL - Cile 23
AT - Austria 22
EC - Ecuador 22
KR - Corea 22
JO - Giordania 20
BJ - Benin 19
CZ - Repubblica Ceca 19
NI - Nicaragua 18
PE - Perù 18
CR - Costa Rica 17
EG - Egitto 17
MY - Malesia 17
IE - Irlanda 16
KE - Kenya 16
KZ - Kazakistan 16
UZ - Uzbekistan 16
DO - Repubblica Dominicana 15
LV - Lettonia 15
NE - Niger 15
AE - Emirati Arabi Uniti 14
AO - Angola 14
CI - Costa d'Avorio 14
CM - Camerun 14
DZ - Algeria 14
JM - Giamaica 14
MZ - Mozambico 14
NO - Norvegia 14
NP - Nepal 14
PT - Portogallo 14
PY - Paraguay 14
RO - Romania 14
GN - Guinea 13
HR - Croazia 13
IL - Israele 13
IR - Iran 13
LA - Repubblica Popolare Democratica del Laos 13
SI - Slovenia 13
TJ - Tagikistan 13
VE - Venezuela 13
YT - Mayotte 13
CU - Cuba 12
GT - Guatemala 12
HN - Honduras 12
LB - Libano 12
MA - Marocco 12
ML - Mali 12
SN - Senegal 12
TW - Taiwan 12
BA - Bosnia-Erzegovina 11
BO - Bolivia 11
CG - Congo 11
GF - Guiana Francese 11
KG - Kirghizistan 11
TT - Trinidad e Tobago 11
UG - Uganda 11
ET - Etiopia 10
HT - Haiti 10
LC - Santa Lucia 10
MD - Moldavia 10
MN - Mongolia 10
NZ - Nuova Zelanda 10
RS - Serbia 10
SK - Slovacchia (Repubblica Slovacca) 10
TZ - Tanzania 10
AM - Armenia 9
AZ - Azerbaigian 9
BG - Bulgaria 9
GM - Gambi 9
Totale 9.441
Città #
Ashburn 507
Singapore 473
San Jose 449
Hong Kong 336
Fairfield 217
Santa Clara 156
Council Bluffs 141
Ho Chi Minh City 129
Milan 126
Los Angeles 125
Hanoi 114
Rome 108
Chandler 102
Beijing 101
Woodbridge 99
Cambridge 93
Seattle 92
Houston 86
Padova 77
Wilmington 70
Boardman 62
New York 52
Bytom 40
Lauterbourg 39
Padua 38
Ann Arbor 31
Princeton 31
San Diego 31
Da Nang 30
Helsinki 30
Dallas 29
Medford 29
Munich 29
Des Moines 28
Naples 26
Haiphong 24
Montreal 24
São Paulo 23
Chicago 22
Guangzhou 21
Tokyo 21
Toronto 21
The Dalles 20
Bologna 19
Buffalo 19
Cotonou 19
Vicenza 19
Atlanta 18
Denver 18
Managua 18
Roxbury 18
Amman 17
Orem 17
Tashkent 16
Verona 16
Hefei 15
Niamey 15
Phoenix 15
Riga 15
Abidjan 14
Baghdad 14
Frankfurt am Main 14
London 14
Turku 14
Cairo 13
Conakry 13
Dublin 13
Nairobi 13
San Francisco 13
San José 13
Bamako 12
Bogotá 12
Dakar 12
Dushanbe 12
Maputo 12
Bergamo 11
Can Tho 11
Geneva 11
Havana 11
Johannesburg 11
Lima 11
Pune 11
Riyadh 11
Turin 11
Kampala 10
Lappeenranta 10
Manchester 10
Prague 10
Quito 10
Ulan Bator 10
Venice 10
Vienna 10
Vientiane 10
Amsterdam 9
Bishkek 9
Castries 9
Dar es Salaam 9
Istanbul 9
Jakarta 9
Kingston 9
Totale 5.036
Nome #
Cognitive and Brain Imaging Changes in Parkinsonism 622
Validation of the Italian version of the Parkinson's Disease- Cognitive Functional Rating Scale 430
Double-blind randomized trial of t-DCS versus sham in Parkinson patients with mild cognitive impairment receiving cognitive training 352
A New MRI Measure to Early Differentiate Progressive Supranuclear Palsy From De Novo Parkinson's Disease in Clinical Practice: An International Study 318
Safety and efficacy of cognitive rehabilitation in PD with cognitive impairments 302
Brain connectivity changes associated with t‐DCS and cognitive training plus cognitive training in Parkinson's disease with mild cognitive impairment 300
Automated MRI Classification in Progressive Supranuclear Palsy: A Large International Cohort Study 259
Asymmetric Dopamine Transporter Loss Affects Cognitive and Motor Progression in Parkinson's Disease 251
Differences in cognitive profiles between Lewy body and Parkinson’s disease dementia 249
The effectiveness of an immersive virtual reality and telemedicine-based cognitive intervention on prospective memory in Parkinson’s disease patients with mild cognitive impairment and healthy aged individuals: design and preliminary baseline results of a placebo-controlled study 239
Optimal MMSE and MoCA cutoffs for cognitive diagnoses in Parkinson's disease: A data-driven decision tree model 238
Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes 234
Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease 229
Biomarkers of aging in frailty and age-associated disorders: State of the art and future perspective 228
Brain Amyloid Contribution to Cognitive Dysfunction in Early-Stage Parkinson's Disease: The PPMI Dataset 218
The interplay between asymmetric dopaminergic degeneration, brain structural changes and cognition in de-novo PD: The PPMI dataset 211
Quantification of Brain β-Amyloid Load in Parkinson's Disease With Mild Cognitive Impairment: A PET/MRI Study 208
Cognitive and mental health changes and their vulnerability factors related to COVID-19 lockdown in Italy 206
Effects of virtual reality cognitive training on executive function and prospective memory in Parkinson's disease and healthy aging 202
The contribution of beta-amyloid to dementia in Lewy body diseases: a 1-year follow-up study 201
Brain structural profile of multiple system atrophy patients with cognitive impairment 195
The pharmacological management of the behavioral aspects of Parkinson’s disease: an update 191
Dynamic functional connectivity changes associated with dementia in Parkinson's disease 180
Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy 178
Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy-Parkinsonism From Parkinson's Disease 177
Diverse preferences, different solutions: Exploring remote monitoring preferences in Parkinson's disease through a discrete choice experiment 171
Detecting amyloid and tau pathology in Parkinson’s disease, 4R-tauopathies and control subjects with plasma pTau217 171
Attitudes Toward the Adoption of Remote Patient Monitoring and Artificial Intelligence in Parkinson’s Disease Management: Perspectives of Patients and Neurologists 163
Gender differences in the effects of emotion induction on intertemporal decision-making 161
Anatomical profile of cognitive impairment in MSA 161
Brain Dynamics Complexity as a Signature of Cognitive Decline in Parkinson's Disease 158
Nonmotor Symptoms and Natural History of Parkinson's Disease: Evidence From Cognitive Dysfunction and Role of Noninvasive Interventions 156
Do Old Errors Always Lead to New Truths? A Randomized Controlled Trial of Errorless Goal Management Training in Brain-Injured Patients 153
Impact of Cognitive Profile on Impulse Control Disorders Presence and Severity in Parkinson's Disease 151
One-year into COVID-19 pandemic: Decision-making and mental-health outcomes and their risk factors 141
Cognitive profiling in patients with Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy: a 15-month longitudinal study 141
Cognitive impairment in multiple system atrophy 139
The role of blood-based biomarkers in Parkinsonian disorders, Alzheimer's disease and frontotemporal dementia 137
Cognitive Rehabilitation in Parkinson's Disease: Is it Feasible? 137
Brain structural abnormalities in multiple system atrophy patients with cognitive impairment 137
Multimodal PET/MRI Study of Connectivity in Cognitively Impaired Patients with Parkinson’s Disease 133
Reply: Dynamic functional connectivity changes in Lewy body disease 126
Performance at the Category-Exemplars language test (CATEX) in Parkinson's disease and Huntington's disease Italian population 121
Profile and progression of cognitive deficits in Progressive Supranuclear Palsy, Multiple System Atrophy and Parkinson's Disease 119
Resting-state EEG changes associated with cognitive decline in Parkinson’s disease: a systematic review 110
MoCA vs. MMSE sensitivity as screening instruments of cognitive impairment in PD, MSA and PSP patients 104
Periodic and Aperiodic Electroencephalographic Rhythms During Vigilance Transitions in Alzheimer's Disease Mild Cognitive Impairment 80
Erratum: Double-blind Randomized Trial of tDCS Versus Sham in Parkinson Patients with Mild Cognitive Impairment Receiving Cognitive Training (Brain Stimulation (2015) 8 (1223-1225) DOI: 10.1016/j.brs.2015.07.043) 72
Reply: Reflections on the cognitive training of immersive virtual reality in executive function and prospective memory for PD-MCI patients and healthy older adults 53
Abnormal Resting-State EEG delta and alpha rhythms in Huntington's and Alzheimer's Diseases: An exploratory study 51
null 40
The Effectiveness of i-Virtual Reality and Telemedicine Based Cognitive Approach for Rehabilitation of Prospective Memory in Individuals With Parkinson's Disease and Mild Cognitive Impairment: A Randomized-Controlled Trial 34
Blood neurodegeneration biomarkers and the muscle–brain axis in older adults: physical performance as a functional mediator of cognition 30
Reply: Immersive virtual reality for cognitive training in Parkinson's disease – Future directions and neuroimaging perspectives 27
Attention/Working Memory and Executive Function in Parkinson's Disease: Review, Critique, and Recommendations 27
Glymphatic clearance as revealed by diffusion tensor imaging along the perivascular space (DTI-ALPS) is associated with Alzheimer's disease neuropathology and periodic rsEEG alpha rhythms in mild cognitive impairment participants 22
Plasma p-tau217 Versus p-tau181 in Parkinson's Disease: Differential Associations with Alzheimer's Disease-Related Neurostructural Changes and Cognitive Function 22
Associations of IL-17 and TGF-β1 with physical frailty in older adults 20
Distinct neurostructural, cognitive, and neuropsychiatric associations of plasma p-tau217, and Aβ42/40 in Parkinson’s disease and aging cohorts 18
Abnormal periodic and aperiodic resting-state electroencephalographic markers in Lewy body and Alzheimer’s diseases with cognitive decline 18
REMS versus DXA in older adults: diagnostic concordance for osteoporosis in a geriatric outpatient population 18
null 4
Totale 9.944
Categoria #
all - tutte 26.893
article - articoli 20.079
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 539
Totale 47.511


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022377 0 0 32 14 13 92 25 17 21 51 28 84
2022/2023396 58 8 15 20 60 53 4 46 72 10 33 17
2023/2024520 32 45 40 40 44 58 64 48 28 16 54 51
2024/20251.409 40 108 50 75 183 43 112 120 123 88 174 293
2025/20265.418 270 314 606 740 387 217 1.021 457 540 366 251 249
2026/20271.116 379 679 58 0 0 0 0 0 0 0 0 0
Totale 9.944